Clinical trials serve as crucial medical research that aims at developing or establishing better treatment or diagnostic techniques for the betterment of human lives. Clinical trials using Recombinant Interferon Alfa-2B target various conditions and a few are listed below: Melanoma (Skin), Protocol Specific Unspecified Adult Solid Tumor, Cancer and Neuroendocrine Carcinoma. 1 clinical studies are underway to develop Recombinant Interferon Alfa-2B in Lima, OH.
Some of these active clinical studies are listed below:
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced High-Risk Neuroendocrine Tumor
After enrolling in a research study you may receive medical evaluation and treatment at no cost. We encourage you to enroll in a Recombinant Interferon Alfa-2b clinical trial and help create new cures!